EverPoint Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$21.1M Buy
+100,450
New +$20.8M 0.39% 61
2015
Q4
Sell
-19,000
Closed -$5.16M 565
2015
Q3
$5.16M Sell
19,000
-36,000
-65% -$11.1M 0.13% 209
2015
Q2
$16.7M Sell
55,000
-30,000
-35% -$8.95M 0.3% 95
2015
Q1
$25.3M Sell
85,000
-80,000
-48% -$22.8M 0.48% 54
2014
Q4
$42.5M Buy
165,000
+82,500
+100% +$20.6M 0.96% 10
2014
Q3
$19.9M Hold
82,500
0.46% 55
2014
Q2
$18.4M Buy
+82,500
New +$17.1M 0.38% 61

Other funds holding AGN

EverPoint Asset Management's AGN Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Allergan plc (AGN) in Q4 2016: 100,450 shares worth $21.1M. The stake represents 0.39% of the portfolio and ranks #61 among its holdings. This is a return to the name: EverPoint Asset Management previously reported a position in AGN as recently as Q3 2015.

EverPoint Asset Management first reported a position in AGN in Q2 2014 and has held it in 7 quarters since. The position peaked at $42.5M in Q4 2014. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • EverPoint Asset Management held 100,450 shares of Allergan plc worth $21.1M as of Q4 2016.
  • Allergan plc was a new EverPoint Asset Management position in Q4 2016.
  • Allergan plc made up 0.39% of EverPoint Asset Management's portfolio in Q4 2016, its #61 holding.
  • EverPoint Asset Management first reported a position in Allergan plc in Q2 2014 and has held it in 7 quarters since.
  • EverPoint Asset Management's Allergan plc position peaked at $42.5M in Q4 2014.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.